International MPN Experts Discuss the Future of MPN Treatments
- Peter Löffelhardt
- 2 days ago
- 1 min read
4th MPN Spring Symposium | Barcelona | May 2024
What’s next in the treatment of myeloproliferative neoplasms (MPNs)?
In this exclusive video, four international MPN leaders, shared their perspectives about the future of MPNs:
Prof. Ruben Mesa, M.D., FACP, Executive Director of Atrium Health Levine Cancer Institute and Vice Dean for Cancer Programs at Wake Forest University School of Medicine (USA)
Dr. Lucia Masarova, M.D., Assistant Professor in the Department of Leukemia, Division of Cancer Medicine at MD Anderson Cancer Center (USA)
Dr. Marina Kremyanskaya, M.D., Ph.D., Associate Professor of Medicine, Hematology and Medical Oncology at the Icahn School of Medicine at Mount Sinai (USA)
Prof. Martin Ellis, M.D., Chairman of the Hematology Institute and Translational Hemato-Oncology Laboratory and Senior Physician at Meir Medical Center, affiliated with Tel Aviv University (Israel)
Topics they talked about:
Personalized therapies and how to adapt treatment to each patient
The potential of new drug combinations and clinical trials
Why monitoring allele burden and mutations matters
The importance of quality of life and holistic care
And the value of collaboration between patients, physicians and pharmaceutical companies
A must-watch session for anyone affected by or working in MPNs. 👉 Watch the full video here
We are also excited to announce the 5th MPN Spring Symposium, which will take place from November 7th to 9th, 2025, in Barcelona. This global event will bring together patients, physicians and pharmaceutical leaders to present new tools, projects and collaborations that are shaping the future of MPN care.
If you want to receive the full program first, you can pre-register to assist virtually now:
Comments